| Year |
Citation |
Score |
| 2021 |
Goedegebuure RSA, Kleibeuker EA, Buffa FM, Castricum KCM, Haider S, Schulkens IA, Ten Kroode L, van den Berg J, Jacobs MAJM, van Berkel AM, van Grieken NCT, Derks S, Slotman BJ, Verheul HMW, Harris AL, et al. Interferon- and STING-independent induction of type I interferon stimulated genes during fractionated irradiation. Journal of Experimental & Clinical Cancer Research : Cr. 40: 161. PMID 33964942 DOI: 10.1186/s13046-021-01962-2 |
0.419 |
|
| 2020 |
Bridges E, Sheldon H, Kleibeuker E, Ramberger E, Zois C, Barnard A, Harjes U, Li JL, Masiero M, MacLaren R, Harris A. RHOQ is induced by DLL4 and regulates angiogenesis by determining the intracellular route of the Notch intracellular domain. Angiogenesis. PMID 32506201 DOI: 10.1007/S10456-020-09726-W |
0.379 |
|
| 2016 |
Kleibeuker EA, Fokas E, Allen PD, Kersemans V, Griffioen AW, Beech J, Im JH, Smart SC, Castricum KC, van den Berg J, Schulkens IA, Hill SA, Harris AL, Slotman BJ, Verheul HM, et al. Low dose angiostatic treatment counteracts radiotherapy-induced tumor perfusion and enhances the anti-tumor effect. Oncotarget. PMID 27780936 DOI: 10.18632/oncotarget.12814 |
0.39 |
|
| 2016 |
Chen L, Zeng X, Kleibeuker E, Buffa F, Barberis A, Leek RD, Roxanis I, Zhang W, Worth A, Beech JS, Harris AL, Cai S. Paracrine effect of GTP cyclohydrolase and angiopoietin-1 interaction in stromal fibroblasts on tumor Tie2 activation and breast cancer growth. Oncotarget. PMID 26814432 DOI: 10.18632/oncotarget.6981 |
0.474 |
|
| 2012 |
Kleibeuker EA, Griffioen AW, Verheul HM, Slotman BJ, Thijssen VL. Combining angiogenesis inhibition and radiotherapy: a double-edged sword. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 15: 173-82. PMID 22561672 DOI: 10.1016/j.drup.2012.04.002 |
0.309 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2015 |
Schulkens IA, Kleibeuker EA, Castricum KC, Griffioen AW, Thijssen VL. Examination of the role of galectins and galectin inhibitors in endothelial cell biology. Methods in Molecular Biology (Clifton, N.J.). 1207: 285-91. PMID 25253147 DOI: 10.1007/978-1-4939-1396-1_18 |
0.292 |
|
| 2015 |
Kleibeuker EA, Schulkens IA, Castricum KC, Griffioen AW, Thijssen VL. Examination of the role of galectins during in vivo angiogenesis using the chick chorioallantoic membrane assay. Methods in Molecular Biology (Clifton, N.J.). 1207: 305-15. PMID 25253149 DOI: 10.1007/978-1-4939-1396-1_20 |
0.248 |
|
| 2015 |
Kleibeuker EA, Ten Hooven MA, Verheul HM, Slotman BJ, Thijssen VL. Combining radiotherapy with sunitinib: lessons (to be) learned. Angiogenesis. 18: 385-95. PMID 26202788 DOI: 10.1007/s10456-015-9476-3 |
0.196 |
|
| 2015 |
Kleibeuker EA, Ten Hooven MA, Castricum KC, Honeywell R, Griffioen AW, Verheul HM, Slotman BJ, Thijssen VL. Optimal treatment scheduling of ionizing radiation and sunitinib improves the antitumor activity and allows dose reduction. Cancer Medicine. 4: 1003-15. PMID 25828633 DOI: 10.1002/cam4.441 |
0.112 |
|
| 2014 |
Kleibeuker E, Castricum K, Ten Hooven M, Van den Berg J, Griffioen A, Slotman B, Verheul H, Thijssen V. PO-0955: Improving the radio-sensitizing effect of sunitinib by drug-specific scheduling Radiotherapy and Oncology. 111: S129. DOI: 10.1016/S0167-8140(15)31073-2 |
0.056 |
|
| Hide low-probability matches. |